<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药时代 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-17T11:18:23+08:00</updated>
  <subtitle>欢迎您走进药时代！这是一个千载难逢的医药研发新时代！我们分享最新的有价值的行业资讯，讲述医药背后感人的故事，举办形式多样、内容丰富的线上线下活动，与朋友们一起学习成长，将新药研发事业进行到底，让新药带给世界更多更大的健康</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>10亿美元收购Prevail，礼来快速充盈早期神经疾病管线</title>
    <updated>2020-12-17T07:41:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/XS3HjB0EzKOcYoVoVS7EUA</id>
    <link href="https://mp.weixin.qq.com/s/XS3HjB0EzKOcYoVoVS7EUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PCSK9抑制剂再增新员：三强鼎力之势将定</title>
    <updated>2020-12-17T07:41:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/9lOkI9_jjPcNiLQaLpTWqQ</id>
    <link href="https://mp.weixin.qq.com/s/9lOkI9_jjPcNiLQaLpTWqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>拓展Tau蛋白PET示踪剂的使用与研发 新旭生技喜迎新伙伴</title>
    <updated>2020-12-17T07:41:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/OQPAea5ZPgOam-qaRq-uog</id>
    <link href="https://mp.weixin.qq.com/s/OQPAea5ZPgOam-qaRq-uog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>HLA-I分子加工和递呈抗原功能受损是免疫检查点抑制剂耐药的重要原因</title>
    <updated>2020-12-17T07:41:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/MRfIkqRGOB9DUb2JSsD6sQ</id>
    <link href="https://mp.weixin.qq.com/s/MRfIkqRGOB9DUb2JSsD6sQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>尚未成药靶标Aurora：20多个品种研发失败，多家公司仍前赴后继</title>
    <updated>2020-12-17T07:41:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/ZJJZF0xbr5o7iH3h3h_mSQ</id>
    <link href="https://mp.weixin.qq.com/s/ZJJZF0xbr5o7iH3h3h_mSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药时代诚聘英才，居家办公，共筑健康天下！</title>
    <updated>2020-12-17T07:41:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/QN1jEvVniYJ0UWwjsaWAdQ</id>
    <link href="https://mp.weixin.qq.com/s/QN1jEvVniYJ0UWwjsaWAdQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>联盟喜讯｜知名投资机构联手投资2.8亿元，创新药新锐众生睿创完成B轮融资</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/ESYZJwXQgmpL6L0jreze6A</id>
    <link href="https://mp.weixin.qq.com/s/ESYZJwXQgmpL6L0jreze6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东再签NASH领域新合作，刚上市的Aligos凭借拿手绝活寡核苷酸药物获得青睐</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/cNpH-agFfwHoDLnMMPhwmQ</id>
    <link href="https://mp.weixin.qq.com/s/cNpH-agFfwHoDLnMMPhwmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>骨髓瘤治疗新进展，全新作用机制药物Selinexor（ATG-010）三种治疗方案入选最新版NCCN®多发性骨髓瘤诊疗指南</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/_ArBzQPDvCh_2JDt88l7YQ</id>
    <link href="https://mp.weixin.qq.com/s/_ArBzQPDvCh_2JDt88l7YQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>按图索骥？Nature封面研究：科学家们摸清了人类癌细胞的转移路线</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/efcnhzSAbcs5voHAjkhOHQ</id>
    <link href="https://mp.weixin.qq.com/s/efcnhzSAbcs5voHAjkhOHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>运气or天才：从DMSO到抗癌药伏立诺他的传奇之路</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/LNHxHklnvkaEj6aLZ6KNBA</id>
    <link href="https://mp.weixin.qq.com/s/LNHxHklnvkaEj6aLZ6KNBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制药公司因疫情获得的巨额融资是否能转化为更多新药？</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/SIrzY3wZwdwrNv0BBtcuyw</id>
    <link href="https://mp.weixin.qq.com/s/SIrzY3wZwdwrNv0BBtcuyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药时代，我们帮您找到理想的合作伙伴！</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/BYx62biteEjFPJ4AHAg3lw</id>
    <link href="https://mp.weixin.qq.com/s/BYx62biteEjFPJ4AHAg3lw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CRISPR编辑过的CAR-T在白血病模型中显现增强的活性</title>
    <updated>2020-12-15T07:47:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/TXteehQ7_o3T7kTTS-VNQg</id>
    <link href="https://mp.weixin.qq.com/s/TXteehQ7_o3T7kTTS-VNQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先声药业与阿尔脉生物就创新药研发达成战略合作</title>
    <updated>2020-12-15T07:47:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/e3cL5oAGuyicYv5B6PTYmA</id>
    <link href="https://mp.weixin.qq.com/s/e3cL5oAGuyicYv5B6PTYmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>颠覆式创新：小分子PD-L1抑制剂能否破解PPI靶点成药难题？</title>
    <updated>2020-12-15T07:47:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/D1F57m6S2URLAaQxfj1Ogg</id>
    <link href="https://mp.weixin.qq.com/s/D1F57m6S2URLAaQxfj1Ogg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>祝贺恒瑞！国家药监局批准PARP抑制剂氟唑帕利胶囊（商品名：艾瑞颐）上市</title>
    <updated>2020-12-15T07:47:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/tFdc7HA_7Ofksa3NEdAA5Q</id>
    <link href="https://mp.weixin.qq.com/s/tFdc7HA_7Ofksa3NEdAA5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅药物发现之——恩格列净</title>
    <updated>2020-12-15T07:47:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/0ADSmYg4Hjr6urF022ycUw</id>
    <link href="https://mp.weixin.qq.com/s/0ADSmYg4Hjr6urF022ycUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DrugTimes, We Help You Find Partners in China!</title>
    <updated>2020-12-15T07:47:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/tB2vGdDN4PcKMvkbm3pzXw</id>
    <link href="https://mp.weixin.qq.com/s/tB2vGdDN4PcKMvkbm3pzXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>投稿 | 390亿美元收购亚力兄！布局罕见病领域，阿斯利康运筹帷幄大棋局</title>
    <updated>2020-12-14T08:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/w6uzc0j6lRMfwkXBWgy3wA</id>
    <link href="https://mp.weixin.qq.com/s/w6uzc0j6lRMfwkXBWgy3wA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>